Ad5‐nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants-Reference-Cited by-同舟云学术

Ad5‐nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants

Published:2022-10 Issue:1 Volume:95 Page:
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:Journal of Medical Virology

Author:

Kong Weiya¹,Zhong Qingyang²,Chen Mingxiao¹,Yu Pei¹,Xu Ruhong³,Zhang Lei⁴,Lai Changchun⁵,Deng Min¹,Zhou Qiang¹,Xiong Shilong¹,Liang Yuemei⁶,Wan Li¹,Lin Meifang¹,Wang Minhong¹,Mai Weikang¹,Chen Lu¹,Lei Yu¹,Qin Nan¹,Zhu Jianqiang¹,Ruan Jianfeng⁷,Huang Qiulan⁸,Kang An⁸,Wang Jun⁹,Li Wenrui⁶,Ji Tianxing¹^ORCID

Affiliation:

1. Clinical Laboratory Medicine Department The Second Affiliated Hospital of Guangzhou Medical University Guangzhou China

2. Department of Infectious Disease Dongguan Ninth People's Hospital Dongguan China

3. Department of Respiratory Dongguan Ninth People's Hospital Dongguan China

4. Department of Kidney Transplant The Second Affiliated Hospital of Guangzhou Medical University Guangzhou China

5. Clinical Laboratory Medicine Department Maoming People's Hospital Maoming China

6. Clinical Laboratory Medicine Department Dongguan Ninth People's Hospital Dongguan China

7. Hospital Infection‐Control Department The Second Affiliated Hospital of Guangzhou Medical University Guangzhou China

8. Department of Medical Examination The Second Affiliated Hospital of Guangzhou Medical University China

9. Immunization Planning Section Haizhu District Center for Disease Control and Prevention Guangzhou China

Funder

Natural Science Foundation of Guangdong Province

Guangzhou Science and Technology Innovation Center

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmv.28163

Reference28 articles.

1. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa

2. Effectiveness of mRNA-1273 against SARS-CoV-2 Omicron and Delta variants

3. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape

4. Landscape of the RBD-specific IgG, IgM, and IgA responses triggered by the inactivated virus vaccine against the Omicron variant

5. Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Specific humoral immune response and XBB variants re-infection risk of hemodialysis patients after Omicron BA.5 infection in China;Vaccine;2024-08

2. Discrimination of SARS-CoV-2 omicron variant and its lineages by rapid detection of immune-escape mutations in spike protein RBD using asymmetric PCR-based melting curve analysis;Virology Journal;2023-08-25

3. A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov;Expert Review of Vaccines;2023-08

4. Handheld NIR-to-NIR Platform for on-site evaluating protective neutralizing antibody against SARS-CoV-2 ancestral strain and Omicron variant after vaccination or infection;Biosensors and Bioelectronics;2023-08

5. Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8;Virology Journal;2023-05-29